T3P-Y058-739
N/A
Report date: 2023/01/01 08:30:25
NME
Base Information
Drug NameT3P-Y058-739
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesT3 Pharmaceuticals AG
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A